Comparative performance of QuantiFERON-TB Gold versus skin test with tuberculosis recombinant allergen (Diaskintest) among patients with suspected pulmonary tuberculosis in Russia

Tuberculosis (TB) is one of the top 10 causes of death worldwide and the primary cause of death due to any single infectious agent. In 2017, approximately 10 million people developed TB, and 1.3 million died from the disease (WHO, 2018). According to a recent estimate, approximately 1.7 billion people have a latent TB infection (LTBI) (Houben and Dodd, 2016), which can progress to active TB during the person ’s lifetime. As long as individuals with LTBI exist, TB elimination will not be feasible (ECDC, 2018).
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Source Type: research